| __timestamp | ADMA Biologics, Inc. | argenx SE |
|---|---|---|
| Wednesday, January 1, 2014 | 5915545 | 4579319.93 |
| Thursday, January 1, 2015 | 7177633 | 7504448.39 |
| Friday, January 1, 2016 | 10661037 | 15466459 |
| Sunday, January 1, 2017 | 22760560 | 43793829 |
| Monday, January 1, 2018 | 16985290 | 24564806 |
| Tuesday, January 1, 2019 | 29349083 | 78116087 |
| Wednesday, January 1, 2020 | 42219783 | 44848173 |
| Friday, January 1, 2021 | 80942625 | 497277000 |
| Saturday, January 1, 2022 | 154079692 | 410746000 |
| Sunday, January 1, 2023 | 258214999 | 1226316000 |
Unleashing the power of data
In the competitive landscape of biotechnology, revenue generation is a key indicator of success. Over the past decade, Argenx SE and ADMA Biologics, Inc. have been vying for dominance. From 2014 to 2023, Argenx SE has consistently outpaced ADMA Biologics, with a staggering 1,226% increase in revenue by 2023. In contrast, ADMA Biologics saw a respectable growth of 336% during the same period.
In 2014, both companies started with modest revenues, but by 2023, Argenx SE's revenue soared to over four times that of ADMA Biologics. This remarkable growth trajectory highlights Argenx SE's strategic advancements and market positioning. As the biotech industry continues to evolve, these companies exemplify the dynamic nature of revenue generation and market competition.
Annual Revenue Comparison: Merck & Co., Inc. vs ADMA Biologics, Inc.
Zoetis Inc. and argenx SE: A Comprehensive Revenue Analysis
argenx SE vs Incyte Corporation: Annual Revenue Growth Compared
Who Prioritizes Innovation? R&D Spending Compared for argenx SE and ADMA Biologics, Inc.
argenx SE or Merus N.V.: Who Leads in Yearly Revenue?
Who Generates More Revenue? argenx SE or Xencor, Inc.
United Therapeutics Corporation and ADMA Biologics, Inc.: A Comprehensive Revenue Analysis
Revenue Insights: Incyte Corporation and ADMA Biologics, Inc. Performance Compared
Comparing Revenue Performance: ADMA Biologics, Inc. or PTC Therapeutics, Inc.?
Annual Revenue Comparison: ADMA Biologics, Inc. vs Veracyte, Inc.
Revenue Insights: ADMA Biologics, Inc. and Bausch Health Companies Inc. Performance Compared
Breaking Down Revenue Trends: ADMA Biologics, Inc. vs Viridian Therapeutics, Inc.